http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008019322-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_644c03c3333a4447130f6dd66cfccfc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05757ad754f2541ee4c6cbc71000ef36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db85d5026bd69e7832ba4034fc1fa357
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1732
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 2007-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb4cb5e1d4990bee8af83dc5a939172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4199989c71c4e5e3d7ecb67b69386e92
publicationDate 2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008019322-A3
titleOfInvention Methods of inhibiting and reducing tumor growth using human mannose-binding lectin
abstract The present invention is directed to methods of inhibiting or reducing tumor growth including the step of administering an effective amount of recombinant human mannose-binding lectin to a patient. The methods include administering recombinant human mannose-binding lectin to a patient having colorectal cancer, ovarian cancer, pancreatic cancer, lymphomas, melanomas or myelomas.
priorityDate 2006-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0205833-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416

Total number of triples: 18.